Porphyria [por·fee·ree·uh] is a group of disorders caused by abnormal function of the enzymes involved in the production of heme. Heme is a major component of hemoglobin, the oxygen-carrying component ...

Table 01: Global Acute Intermittent Porphyria Market Size (US$ Mn) Forecast, by Diagnosis, 2020-2034 Table 02: Global Acute Intermittent Porphyria Market Size (US$ Mn) Forecast, by Treatment, ...

Subsequently, the patient was found to have significantly elevated blood lead levels, ultimately leading to a final diagnosis of lead poisoning (suspected ayurvedic use) (44). This case underscores ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

AIP is a type of porphyria that affects approximately 1 in 2,000 people. This article explains what AIP is and outlines its symptoms, causes, risk factors, and more. The body uses a multi-step ...

Among patients with acute hepatic porphyria (AHP) and recurrent attacks, long-term use of givosiran is associated with a decreased annualized attack rate and improved QOL, according to a study in the ...

It tells the tale of class and marriage, while also exploring the tormenting illness of King George III, which at least some experts believe to be porphyria. That's right: while "Queen Charlotte ...

to target the production of pathogenic compounds in people AHP NICE have recommended the use of givosiran, a gene silencing therapy, on the NHS in England, as an option for the treatment of acute ...

Annual rate of composite porphyria attacks for those with acute intermittent porphyria (AIP; n = 89) was the primary end point, and secondary end points included ALA/PBG levels, hemin use, and ...